Fungal necrotizing otitis externa; challenges in diagnosis and therapy

Gaelle Vofo1, Ofir Zavdy2,3, Rona Bourla2,3

  • 1Department of Otolaryngology- Head and Neck Surgery, Hadassah Medical Center, Jerusalem, 91120, Israel.

Abstract

Insights

Necrotizing otitis externa (NOE) treatment decisions for fungal infections lack standardization. A proposed protocol aims to guide antifungal therapy based on clinical and microbiological data for better outcomes.

Area of Science:

  • Infectious Diseases
  • Otolaryngology
  • Mycology

Background:

  • Necrotizing otitis externa (NOE) is a severe infection potentially involving the skull base.
  • The role of fungal pathogens and the necessity of antifungal treatment in NOE are debated.

Purpose of the Study:

  • To evaluate clinical characteristics, diagnostic challenges, and microbiology in fungal NOE.
  • To assess considerations for antifungal therapy in NOE patients.

Main Methods:

  • Retrospective cohort study at two tertiary centers.
  • Comparison of clinical characteristics, microbiology, and disease persistence between patients receiving combined antifungal-antibiotic therapy versus antibiotics alone.

Main Results:

  • Fungi identified in 72% of cultures from combined-treatment group, though reliability was often questioned.
  • Combined therapy patients were younger, had prolonged symptoms, and more cranial nerve palsy.
  • Antifungal therapy decisions were inconsistently made, lacking standardization.

Conclusions:

  • Current antifungal therapy decisions for NOE are not standardized.
  • A protocol integrating clinical and microbiological data is proposed to guide antifungal therapy.
  • Prospective studies are required to validate the proposed protocol and establish treatment guidelines.